Trial Profile
Clinical Trials Insight: 700029248
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 13 Dec 2007
Price :
$35
*
At a glance
- Drugs NP 500 (Primary)
- Indications Metabolic syndrome; Type 2 diabetes mellitus
- Focus Adverse reactions
- Sponsors Napo Pharmaceuticals
- 13 Dec 2007 New trial record.